Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / HUGE - FSD Pharma files application to begin Phase 2 trial of FSD-201 in U.S. and Canada

HUGE - FSD Pharma files application to begin Phase 2 trial of FSD-201 in U.S. and Canada

FSD Pharma Inc.
FSD Pharma (NASDAQ:HUGE) said on Tuesday it had submitted  an application to the U.S. Food and Drug Administration and Health Canada to begin Phase 2 trial of FSD-201 to treat a yet-to-be-disclosed inflammatory disorder. FSD Pharma holds exclusive worldwide (excluding Italy and Spain) licensing rights to FSD-201 for all conditions in all regulatory categories. FSD-201 is expected to be in the mid-stage trials in Q3. Also read - FSD Pharma closes sale of cannabis facility for C$16.4M, to focus on biotech business. (HUGE -5.9%)

For further details see:

FSD Pharma files application to begin Phase 2 trial of FSD-201 in U.S. and Canada
Stock Information
Company Name: FSD Pharma Inc.
Stock Symbol: HUGE
Market: NASDAQ
Website: fsdpharma.com
Menu
HUGE HUGE Quote HUGE Short HUGE News HUGE Articles HUGE Message Board
Get HUGE Alerts

News, Short Squeeze, Breakout and More Instantly...